Adoptive transfer of ex vivo activated memory T-cells with or without cyclophosphamide for advanced metastatic melanoma: Results in 36 patients
Open Access
- 31 December 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (5) , 698-708
- https://doi.org/10.1016/0959-8049(94)00523-8
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Adoptively Transferred ex Vivo Activated Memory T Cells with Cyclophosphamide: Effective Tumor-Specific Chemoimmunotherapy of Advanced Metastatic Murine Melanoma and CarcinomaClinical Immunology and Immunopathology, 1994
- Autolymphocyte TherapyClinical Immunology and Immunopathology, 1994
- Autolymphocyte therapy —I. In vivo tumour-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytesEuropean Journal Of Cancer, 1994
- Distribution and therapeutic effect of intraarterially transferred tumor-infiltrating lymphocytes in hepatic malignancies. A preliminary reportCancer, 1991
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Potentiation of adoptive immunotherapy by cis‐diamminedichloroplatinum(II), but not by doxorubicin, on a disseminated mouse lymphoma and its association with reduction of tumor burdenInternational Journal of Cancer, 1988
- T-Cell Tumor Elimination as a Result of T-Cell Receptor-Mediated ActivationScience, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Functional characterization of T lymphocytes propagated from human lung carcinomasClinical Immunology and Immunopathology, 1986
- ADOPTIVE IMMUNIZATION AGAINST AN ESTABLISHED TUMOR WITH CYTOLYTIC VERSUS MEMORY T CELLSTransplantation, 1984